SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:c9618d05-845c-42cd-9b99-0782d38e361a"
 

Search: onr:"swepub:oai:lup.lub.lu.se:c9618d05-845c-42cd-9b99-0782d38e361a" > Impact of pathogen ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma

Kostin, Alexander I. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Lundgren, Maria N. (author)
Region Skåne
Bulanov, Andrey Y. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
show more...
Ladygina, Elena A. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Chirkova, Karina S. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Gintsburg, Alexander L. (author)
Gamaleya Research Institute of Epidemiology and Microbiology
Logunov, Denis Y. (author)
Gamaleya Research Institute of Epidemiology and Microbiology
Dolzhikova, Inna V. (author)
Gamaleya Research Institute of Epidemiology and Microbiology
Shcheblyakov, Dmitry V. (author)
Gamaleya Research Institute of Epidemiology and Microbiology
Borovkova, Natalia V. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Godkov, Mikhail A. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Bazhenov, Alexey I. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Shustov, Valeriy V. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Bogdanova, Alina S. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Kamalova, Alina R. (author)
Pirogov Russian National Research Medical University (RNRMU)
Ganchin, Vladimir V. (author)
Centre of Social Sector Analytical Development, Moscow
Dombrovskiy, Eugene A. (author)
Centre of Social Sector Analytical Development, Moscow
Volkov, Stanislav E. (author)
Lund University,Lunds universitet,Probability and Inference Theory Group,Forskargrupper vid Lunds universitet,Matematisk statistik,Matematikcentrum,Institutioner vid LTH,Lunds Tekniska Högskola,Lund University Research Groups,Mathematical Statistics,Centre for Mathematical Sciences,Departments at LTH,Faculty of Engineering, LTH
Drozdova, Nataliya E. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
Petrikov, Sergey S. (author)
N.V. Sklifosovsky Research Institute of Emergency Medicine
show less...
NV. Sklifosovsky Research Institute of Emergency Medicine Region Skåne (creator_code:org_t)
2021-03-18
2021
English.
In: Vox Sanguinis. - : Wiley. - 0042-9007 .- 1423-0410. ; 116:6, s. 665-672
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and objectives: COVID-19 convalescent plasma is an experimental treatment against SARS-CoV-2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels and virus neutralizing activity of the specific antibodies against SARS-CoV2 in convalescent plasma. Materials and methods: A total of 140 plasma doses collected by plasmapheresis from COVID-19 convalescent donors were subjected to pathogen reduction by three methods: methylene blue (M)/visible light, riboflavin (R)/UVB and amotosalen (A)/UVA. To conduct a paired comparison, individual plasma doses were divided into 2 samples that were subjected to one of these methods. The titres of SARS-CoV2 neutralizing antibodies (NtAbs) and levels of specific immunoglobulins to RBD, S- and N-proteins of SARS-CoV-2 were measured before and after pathogen reduction. Results: The methods reduced NtAbs titres differently: among units with the initial titre 80 or above, 81% of units remained unchanged and 19% decreased by one step after methylene blue; 60% were unchanged and 40% decreased by one step after amotosalen; after riboflavin 43% were unchanged and 50% (7%, respectively) had a one-step (two-step, respectively) decrease. Paired two-sample comparisons (M vs. A, M vs. R and A vs. R) revealed that the largest statistically significant decrease in quantity and activity of the specific antibodies resulted from the riboflavin treatment. Conclusion: Pathogen reduction with methylene blue or with amotosalen provides the greater likelihood of preserving the immunological properties of the COVID-19 convalescent plasma compared to riboflavin.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Keyword

amotosalen
COVID-19 convalescent plasma
methylene blue
NtAbs
pathogen reduction
riboflavin

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view